Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
10:23am, Thursday, 23'rd Mar 2023
Eli Lilly didn't generate much growth last year, but its future looks promising. Mounjaro has the potential to be a game-changing product for the business.
1 Stock Down 9% in 2023 to Buy and Hold Forever
08:15am, Thursday, 23'rd Mar 2023
Eli Lilly is one of the biggest names in the diabetes drugs market. But the company's lineup and pipeline extend well beyond this area.
Eli Lilly: Best-Now Near-Term Price Gains Pharmaceuticals Stock
12:32am, Thursday, 23'rd Mar 2023
84% of shares held by 3370 “institutional” investors, with over 80% of its $315 Billion market capitalization traded in a year. Not a buy-to-hold because prior forecasts like today's 8-to-1 wins t
Alzheimer's Blood Test That Could Help Diagnose Disease Earlier Is Being Developed By Eli Lilly And Roche
09:09am, Wednesday, 22'nd Mar 2023
If approved, the test could streamline the diagnostic journey and help patients get earlier access to future Alzheimer's treatments, Roche said.
Eli Lilly Is Priced for Perfection in the Obesity Market
09:00am, Wednesday, 22'nd Mar 2023
The company has outperformed its pharma peers in recent years, but its valuation leaves little room for error.
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
04:13pm, Tuesday, 21'st Mar 2023
Stock market investors have been on a rollercoaster ride over the past year. The Federal Reserve continues to be hawkish in controlling inflation.
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:43am, Tuesday, 21'st Mar 2023
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Beat the Dow Jones With This Unstoppable Dividend Stock
10:15am, Tuesday, 21'st Mar 2023
Eli Lilly possesses a deep product portfolio and pipeline. The company's rapid dividend growth should continue.
Sanofi becomes latest to cut insulin prices, joins Novo Nordisk, Eli Lilly
10:25am, Friday, 17'th Mar 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to report that Sanofi has become the latest major drug company to slash insulin prices, capping the cost at $35.
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk
05:45pm, Thursday, 16'th Mar 2023
The French company will cap the monthly cost of insulin at $35, after Novo Nordisk and Eli Lilly also announced major price cuts earlier this month.
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
04:45pm, Thursday, 16'th Mar 2023
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
Novo Nordisk to lower prices of some insulins, following similar move by Lilly
08:45am, Tuesday, 14'th Mar 2023
Novo Nordisk DK:NOVO.B NVO said that it is lowering the prices of several insulin products by up to 75% starting in 2024. The company's U.S.-listed shares were up about 1.0% in premarket trading on Tu
Why Eli Lilly Stock Cruised to a 3% Gain on Monday
06:50pm, Monday, 13'th Mar 2023
Prominent stock watcher Wells Fargo became sharply more bullish on the company. Analyst Mohit Bansal upped his recommendation from hold to an effective buy.
Eli Lilly suffers setback in Alzheimer's treatment plans
01:00pm, Thursday, 09'th Mar 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the setback Eli Lilly is facing for one of its Alzheimer's treatment drugs while it looks to a phase 3 trial for another drug.
Eli Lilly's Decade-Long Effort In Alzheimer's Disease Just Failed
09:37am, Thursday, 09'th Mar 2023
Eli Lilly stock and Biogen stock diverged Thursday after Lilly said a decade-long study of an Alzheimer's treatment definitively failed. The post Eli Lilly's Decade-Long Effort In Alzheimer's Disease
